To include your compound in the COVID-19 Resource Center, submit it here.

RaQualia, Maruho in deal for sodium channel blocker

RaQualia Pharma Inc. (JASDAQ:4579) granted Maruho

Read the full 63 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE